• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

病毒样颗粒疫苗可预防犬流感病毒 H3N2 感染犬。

Virus-like particle vaccine protects against H3N2 canine influenza virus in dog.

机构信息

Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, 1 Hwayang-dong, Gwangjin-gu, Seoul 143-701, Republic of Korea.

出版信息

Vaccine. 2013 Jul 11;31(32):3268-73. doi: 10.1016/j.vaccine.2013.05.023. Epub 2013 May 22.

DOI:10.1016/j.vaccine.2013.05.023
PMID:23707159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4009491/
Abstract

In the present study, virus-like particles (VLPs) were evaluated as a candidate veterinary vaccine against canine influenza virus (CIV) subtype H3N2. Specific pathogen-free (SPF) beagle dogs received a single injection of a VLP vaccine containing hemagglutinin (HA) and M1 protein of CIV H3N2 (H3 HA VLP). The vaccine was tested at 3 different doses with an adjuvant and 1 dose without an adjuvant. To evaluate the immunogenicity and protective efficacy of the H3 HA VLP vaccine, we performed hemagglutination inhibition tests to determine serological immune responses and conducted challenge studies using SPF beagle dogs. The addition of Montanide ISA 25 adjuvant significantly increased the immunogenicity of the H3 HA VLP vaccine. The experimental infection study showed that a single dose of H3 HA VLP vaccine induced protection against wild-type virus challenge in dogs. These results provide support for continued development of the VLP as an animal vaccine against influenza virus.

摘要

在本研究中，病毒样颗粒 (VLPs) 被评估为一种针对犬流感病毒 (CIV) 亚型 H3N2 的候选兽用疫苗。特定无病原体 (SPF) 比格犬接受了单次注射含有血凝素 (HA) 和 CIV H3N2 M1 蛋白的 VLP 疫苗 (H3 HA VLP)。该疫苗在 3 种不同剂量下进行了测试，一种含有佐剂，一种不含有佐剂。为了评估 H3 HA VLP 疫苗的免疫原性和保护效力，我们进行了血凝抑制试验以确定血清学免疫反应，并使用 SPF 比格犬进行了攻毒研究。添加 Montanide ISA 25 佐剂显著提高了 H3 HA VLP 疫苗的免疫原性。实验感染研究表明，单次剂量的 H3 HA VLP 疫苗可诱导犬对野毒株的保护。这些结果为继续开发 VLP 作为流感病毒的动物疫苗提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/9c597defcfcb/nihms573238f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/735d2215b2f5/nihms573238f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/36c2c82c3c47/nihms573238f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/ef587f423b27/nihms573238f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/7900c6f2c9d6/nihms573238f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/9c597defcfcb/nihms573238f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/735d2215b2f5/nihms573238f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/36c2c82c3c47/nihms573238f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/ef587f423b27/nihms573238f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/7900c6f2c9d6/nihms573238f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b2f/4009491/9c597defcfcb/nihms573238f5.jpg

相似文献

1
Virus-like particle vaccine protects against H3N2 canine influenza virus in dog.病毒样颗粒疫苗可预防犬流感病毒 H3N2 感染犬。
Vaccine. 2013 Jul 11;31(32):3268-73. doi: 10.1016/j.vaccine.2013.05.023. Epub 2013 May 22.
2
Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.病毒样颗粒疫苗对致死性流感病毒攻击提供了完全保护。
Viral Immunol. 2005;18(2):365-72. doi: 10.1089/vim.2005.18.365.
3
Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.在对历史 H3N2 流感病毒无预存免疫的雪貂中引发针对未来 20 年 H3N2 共循环流感病毒变异株的保护性抗体。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.00946-18. Print 2019 Feb 1.
4
Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.通过计算优化的广泛反应性血凝素可引发针对一组H3N2流感病毒共同流行变体的血凝抑制抗体。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01581-17. Print 2017 Dec 15.
5
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.H9N2 禽流感病毒样颗粒疫苗提供保护免疫，并为区分感染动物和接种疫苗动物提供了一种策略。
Vaccine. 2011 May 23;29(23):4003-7. doi: 10.1016/j.vaccine.2011.03.067. Epub 2011 Apr 2.
6
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.流感病毒样颗粒比全病毒灭活流感病毒或重组血凝素引发更广泛的免疫反应。
Vaccine. 2007 May 10;25(19):3871-8. doi: 10.1016/j.vaccine.2007.01.106. Epub 2007 Feb 15.
7
Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.病毒样颗粒（VLP）疫苗对致死性流感病毒攻击提供了完全保护。
Viral Immunol. 2005;18(1):244-51. doi: 10.1089/vim.2005.18.244.
8
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.H5N1病毒样颗粒疫苗可诱导雪貂对高致病性H5N1流感病毒的致死性攻击产生保护作用。
Vaccine. 2008 Oct 3;26(42):5393-9. doi: 10.1016/j.vaccine.2008.07.084. Epub 2008 Aug 14.
9
Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.重组病毒样颗粒在雪貂中引发针对甲型禽流感（H7N9）病毒感染的保护性免疫。
Vaccine. 2015 Apr 27;33(18):2152-8. doi: 10.1016/j.vaccine.2015.03.009. Epub 2015 Mar 13.
10
Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens.单纯表达原文含义，不做额外扩展。 携带 H5HA 的杆状病毒衍生的流感病毒样颗粒单独或与 M1 联合在鸡中的保护效力。
Vet Microbiol. 2013 Mar 23;162(2-4):623-630. doi: 10.1016/j.vetmic.2012.11.035. Epub 2012 Nov 29.

引用本文的文献

1
Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs.犬发热伴血小板减少综合征病毒疫苗的研发。
J Microbiol. 2024 Apr;62(4):327-335. doi: 10.1007/s12275-024-00119-y. Epub 2024 Apr 18.
2
Virus-like Particle Vaccines and Platforms for Vaccine Development.病毒样颗粒疫苗及其疫苗开发平台。
Viruses. 2023 May 2;15(5):1109. doi: 10.3390/v15051109.
3
Influenza A viruses circulating in dogs: A review of the scientific literature.甲型流感病毒在犬群中的流行：文献综述。

本文引用的文献

1
Experimental infection and natural contact exposure of ferrets with canine influenza virus (H3N2).雪貂感染犬流感病毒（H3N2）的实验感染和自然接触暴露。
J Gen Virol. 2013 Feb;94(Pt 2):293-297. doi: 10.1099/vir.0.042473-0.
2
Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity.昆虫细胞来源的流感病毒样颗粒制剂中的残留杆状病毒增强了免疫原性。
PLoS One. 2012;7(12):e51559. doi: 10.1371/journal.pone.0051559. Epub 2012 Dec 7.
3
Characterization of an H3N2 canine influenza virus isolated from Tibetan mastiffs in China.
Open Vet J. 2022 Sep-Oct;12(5):676-687. doi: 10.5455/OVJ.2022.v12.i5.12. Epub 2022 Sep 15.
4
Self-assembled raccoon dog parvovirus VP2 protein confers immunity against RDPV disease in raccoon dogs: in vitro and in vivo studies.自组装貉细小病毒 VP2 蛋白赋予貉对 RDPV 疾病的免疫力：体外和体内研究。
Virol J. 2021 Apr 15;18(1):79. doi: 10.1186/s12985-021-01549-5.
5
Patchless administration of canine influenza vaccine on dog's ear using insertion-responsive microneedles (IRMN) without removal of hair and its in vivo efficacy evaluation.贴片式犬流感疫苗经耳用插入响应型微针（IRMN）给药，无需剃毛，并对其体内疗效进行评估。
Eur J Pharm Biopharm. 2020 Aug;153:150-157. doi: 10.1016/j.ejpb.2020.06.006. Epub 2020 Jun 13.
6
Progress in the development of virus-like particle vaccines against respiratory viruses.抗呼吸道病毒的病毒样颗粒疫苗的研发进展。
Expert Rev Vaccines. 2020 Jan;19(1):11-24. doi: 10.1080/14760584.2020.1711053. Epub 2020 Jan 18.
7
Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.触发因子辅助犬细小病毒 VP2 蛋白在大肠杆菌中自组装成具有高免疫原性的病毒样颗粒。
Virol J. 2018 Jun 19;15(1):103. doi: 10.1186/s12985-018-1013-8.
8
Progress in developing virus-like particle influenza vaccines.病毒样颗粒流感疫苗的研发进展
Expert Rev Vaccines. 2016 Oct;15(10):1281-93. doi: 10.1080/14760584.2016.1175942. Epub 2016 May 5.
9
The application of virus-like particles as vaccines and biological vehicles.病毒样颗粒作为疫苗和生物载体的应用。
Appl Microbiol Biotechnol. 2015 Dec;99(24):10415-32. doi: 10.1007/s00253-015-7000-8. Epub 2015 Oct 10.
10
Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.H7N9流感病毒样颗粒疫苗在BALB/C小鼠中诱导的体液免疫反应的特征
Viruses. 2015 Aug 4;7(8):4369-84. doi: 10.3390/v7082821.
从中国藏獒中分离的一株 H3N2 犬流感病毒的特性研究。
Vet Microbiol. 2013 Mar 23;162(2-4):345-352. doi: 10.1016/j.vetmic.2012.10.006. Epub 2012 Oct 16.
4
Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.抗 HPAI H5N1 粗病毒样颗粒疫苗对鸡的保护效力及其在 DIVA 策略中的应用。
Influenza Other Respir Viruses. 2013 May;7(3):340-8. doi: 10.1111/j.1750-2659.2012.00396.x. Epub 2012 Jun 21.
5
A novel reassortant canine H3N1 influenza virus between pandemic H1N1 and canine H3N2 influenza viruses in Korea.韩国一种新型犬流感 H3N1 病毒，是大流行 H1N1 病毒和犬流感 H3N2 病毒之间的重配病毒。
J Gen Virol. 2012 Mar;93(Pt 3):551-554. doi: 10.1099/vir.0.037739-0. Epub 2011 Nov 30.
6
Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.流感 H5N1 病毒样颗粒的蛋白质组学特征及其保护性免疫原性。
J Proteome Res. 2011 Aug 5;10(8):3450-9. doi: 10.1021/pr200086v. Epub 2011 Jul 8.
7
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals.H9N2 禽流感病毒样颗粒疫苗提供保护免疫，并为区分感染动物和接种疫苗动物提供了一种策略。
Vaccine. 2011 May 23;29(23):4003-7. doi: 10.1016/j.vaccine.2011.03.067. Epub 2011 Apr 2.
8
Virus-like particles in vaccine development.疫苗开发中的病毒样颗粒。
Expert Rev Vaccines. 2010 Oct;9(10):1149-76. doi: 10.1586/erv.10.115.
9
Avian-origin H3N2 canine influenza A viruses in Southern China.中国南方的禽源 H3N2 犬流感 A 病毒。
Infect Genet Evol. 2010 Dec;10(8):1286-8. doi: 10.1016/j.meegid.2010.08.010. Epub 2010 Aug 21.
10
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.将H5N1流感病毒样颗粒通过微针递送至皮肤可在小鼠体内诱导持久的B细胞和T细胞反应。
Clin Vaccine Immunol. 2010 Sep;17(9):1381-9. doi: 10.1128/CVI.00100-10. Epub 2010 Jul 14.